Blood Utilization and Waste Following Implementation of Thromboelastography [0.03%]
凝血弹性图应用后血液使用和浪费情况的改变
Kaitlyn M Shelton,LeeAnn P Walker,Carol A Carman et al.
Kaitlyn M Shelton et al.
Background: Thromboelastography (TEG) is a viscoelastic testing platform that monitors real-time coagulation. This study evaluated changes in blood use and waste following TEG implementation, as well as changes in massive...
Sercan Erol,Evin Kocatürk,Özben Ö Işıklar et al.
Sercan Erol et al.
The Hook Effect in Immunoglobulin A (IgA) Measurements: A Diagnostic Challenge-A Case Series [0.03%]
免疫球蛋白A检测中的HOOK效应：一个诊断挑战-系列案例分析
Aya Almashad,Hoda Hagrass
Aya Almashad
Using Aggregated Proficiency Testing Results to Identify Systematic Error [0.03%]
利用汇总的熟练度测试结果识别系统误差
Uzay Kırbıyık,J Rex Astles
Uzay Kırbıyık
Background: Proficiency testing (PT) should identify systematic errors, which are likely to recur. The Clinical Laboratory Improvement Amendments of 1988 (CLIA) acceptance limits (ALs) include 3 standard deviations (3SD) ...
The Transformative Role of Mass Spectrometry in Diagnosing and Monitoring Monoclonal Gammopathies and Plasma Cell Disorders [0.03%]
质谱在单克隆丙球病和浆细胞疾病诊断及监测中的变革性作用
Gema García de la Rosa,Silvia de Las Heras Flórez,Mercedes Carretero Pérez et al.
Gema García de la Rosa et al.
Background: Mass spectrometry (MS) is emerging as a transformative diagnostic tool for plasma cell disorders, including multiple myeloma, Waldenström macroglobulinemia, and light chain amyloidosis. Traditional diagnostic...
Evaluation of Proteinuria in Plasma Cell Disorders: Shortcomings of Measurements Based on 24-Hour Collections and Alternative Approaches [0.03%]
浆细胞病蛋白尿评估：基于24小时标本检测的不足及替代方法
Glen L Hortin,John M Koomen
Glen L Hortin
Background: Clonal plasma cell disorders, such as multiple myeloma (MM), often cause excretion of monoclonal free light chains (MFLC) into urine that serve as diagnostic markers and can cause renal injury. ...
Mengyuan Ge,Spencer Seely,Michael J Kelner et al.
Mengyuan Ge et al.
Background: While clinical laboratories routinely perform automated chemistry assays on approved specimens (e.g., plasma and serum), the FDA has not evaluated the validity of these assays for nonapproved specimens (e.g., ...
Lorin M Bachmann
Lorin M Bachmann